Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.4443 -0.0082 (-1.81%)
Streaming Delayed Price Updated: 11:34 AM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium
From Ensysce Biosciences
Via ACCESS Newswire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
News headline image
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
From Ensysce Biosciences
Via ACCESS Newswire
Top stock movements in today's session. ↗
Via Chartmill
Thursday's session: most active stocks ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)... 
Via Benzinga
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's pre-market session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)... 
Via Benzinga
News headline image
Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
The Bull Lives Below $1: PRSO, ENSC, TNMG, QNME Stocks to Watch
Via AB Newswire
Topics Artificial Intelligence
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
These stocks are making the most noise in today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-market session. The market value of their outstanding shares is at $3.8 million. TransCode Therapeutics... 
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
Ensysce Biosciences Reports First Quarter 2026 Financial Results
Via ACCESS Newswire
News headline image
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
Via ACCESS Newswire
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
News headline image
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.